SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Oracle Corp. engages in the provision of products and services that address aspects of corporate information technology environments, including applications and infrastructure technologies. It operates through the following business segments: Cloud and License, Hardware, and Services. The Cloud and License segment markets, sells, and delivers enterprise applications and infrastructure technologies through cloud and on-premise deployment models including cloud services and license support offerings. The Hardware segment provides infrastructure technologies including Oracle Engineered Systems, servers, storage, industry-specific hardware, operating systems, virtualization, management, and other hardware-related software. The Services segment offers consulting, advanced support, and education services. The company was founded by Lawrence Joseph Ellison, Robert Nimrod Miner, and Edward A. Oates on June 16, 1977 and is headquartered in Austin, TX.

Oracle Corp.

Oracle shares are facing downward pressure as investors react to the company's aggressive $40 billion financing plan to fund massive capital expenditures for AI infrastructure, despite the company posting strong earnings and a record-breaking $638 billion revenue backlog. The community remains deeply divided, with some investors aggressively buying the dip on the belief that the backlog and AI expansion create a long-term winner, while skeptics warn that the heavy debt and equity dilution are unsustainable burdens.

Super Micro Computer, Inc. engages in the distribution and manufacture of information technology solutions and other computer products. Its products include twin solutions, MP servers, GPU and coprocessor, MicroCloud, AMD solutions, power supplies, SuperServer, storage, motherboards, chassis, super workstations, accessories, SuperRack and server management products. The company was founded by Charles Liang, Yih-Shyan Liaw, Sara Liu, and Chiu-Chu Liu Liang in September 1993 and is headquartered in San Jose, CA.

Super Micro Computer Inc

Super Micro Computer is seeing intense volatility as investors react to a large-scale capital raise and concurrent equity offerings designed to fund a massive $39 billion backlog of AI server orders. While some community members are treating the resulting sell-off as a strategic buying opportunity driven by genuine demand, others remain deeply skeptical, expressing concerns over share dilution, management credibility, and the potential impact of ongoing regulatory scrutiny.

SpaceX

SpaceX is driving intense market speculation as retail and institutional investors prepare for the historic IPO, with the stock seeing massive demand that some traders fear is creating a liquidity trap for early buyers. While the community is actively debating the company's ambitious valuation and long-term AI-focused business model, many are cautioning that the pre-IPO hype may lead to significant volatility once retail traders are finally able to enter the market.

SPDR S&P 500 ETF TRUST - SPDR S&P 500 ETF Trust

Market sentiment remains highly volatile as investors weigh ongoing geopolitical tensions in the Middle East against upcoming inflation data and central bank policy decisions. The community is actively debating the durability of recent relief rallies, with many questioning whether these moves are sustainable or merely short-term liquidity traps driven by algorithmic trading and election-year posturing.

Invesco QQQ Trust Series 1 - Invesco QQQ Trust Series 1

Invesco QQQ Trust is experiencing heightened volatility as investors weigh escalating geopolitical tensions in the Middle East against persistent inflationary pressures following hot PPI data. The community remains divided, with active debates centered on whether current market pullbacks present a tactical buying opportunity or signal a deeper structural correction amidst broader sector rotation.

Xeris Biopharma Holdings, Inc. is a biopharmaceutical company, which engages in developing and commercializing products across a range of therapies. The company has three commercial products: Gvoke, Keveyis, and Recorlev. Gvoke is ready-to-use liquid glucagon for the treatment of severe hypoglycemia. Keveyis is the therapy approved in the United States to treat hyperkalemic, hypokalemic, and related variants of primary periodic paralysis (PPP). Recorlev is a cortisol synthesis inhibitor approved for the treatment of endogenous hypercortisolemia in adult patients with Cushing’s syndrome. Its product also includes Ogluo which is used for the treatment of severe hypoglycemia in adults, adolescents, and children aged 2 years and over with diabetes mellitus. The company was founded by Steven Prestrelski in 2005 and is headquartered in Chicago, IL.

Xeris Biopharma Holdings Inc

Xeris Biopharma is trending as investors react to strong earnings and raised revenue guidance, fueling optimism about its core product growth and pipeline potential. Community sentiment remains bullish, with many focusing on the long-term blockbuster potential of its specialty pharmaceutical portfolio and the upcoming Phase 3 advancement of its pipeline assets.

Meta Platforms, Inc. engages in the development of social media applications. It builds technology that helps people connect and share, find communities, and grow businesses. It operates through the Family of Apps (FoA) and Reality Labs (RL) segments. The FoA segment consists of Facebook, Instagram, Messenger, WhatsApp, and other services. The RL segment includes augmented, mixed and virtual reality related consumer hardware, software, and content. The company was founded by Mark Elliot Zuckerberg, Dustin Moskovitz, Chris R. Hughes, Andrew McCollum, and Eduardo P. Saverin on February 4, 2004, and is headquartered in Menlo Park, CA.

Meta Platforms Inc - Ordinary Shares - Class A

Meta Platforms Inc

Meta Platforms is facing intense investor scrutiny as concerns over aggressive capital expenditures and potential share dilution weigh on the stock despite its strong ad revenue growth. The community remains deeply divided, with bulls pointing to the company's attractive valuation and massive scale, while bears emphasize legal risks, AI execution challenges, and the potential for a significant downturn.

Tidal Trust II - Defiance Daily Target 2x Long SMCI ETF

Defiance Daily Target 2X Long SMCI ETF

DraftKings, Inc. is a digital sports entertainment and gaming company, which engages in the provision of online sports betting, online casino, daily fantasy sports product offerings, DraftKings Marketplace, retail sportsbook, media, and other consumer product offerings. The company was founded by Jason D. Robins, Matthew Kalish, and Paul Liberman on December 31, 2011 and is headquartered in Boston, MA.

DraftKings Inc. - Ordinary Shares - Class A

DraftKings Inc

DraftKings is gaining significant momentum as investors digest strong performance data from its prediction market platform and anticipate a surge in betting volume surrounding the upcoming World Cup and professional sports finals. The stock is currently the focus of intense community debate, with bulls citing a potential breakout and long-term tailwinds from expanded product offerings, while skeptics remain critical of management's history of underperformance and persistent volatility.

Atomera, Inc. engages in the development, commercialization, and licensing of proprietary processes and technologies for the semiconductor industry. It developed Mears Silicon Technology, which increases performance and power efficiency in semiconductor transistors. The company was founded by Robert Mears on November 26, 2001 and is headquartered in Los Gatos, CA.

Atomera Inc

Atomera shares have experienced significant volatility following a quarterly report that revealed lower-than-anticipated revenue and a moderated timeline for commercial milestones. While the community is actively debating the company's long-term potential in next-generation chip architectures, recent price action is being driven by institutional rebalancing and a cooling of speculation regarding immediate licensing deals.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Transcat Inc. Q4 Profit Drops

(RTTNews) - Transcat Inc. (TRNS) released earnings for fourth quarter that Drops, from the same period last year...

Transcat (TRNS) Q4 2026 Earnings Transcript

@media (max-width: 768px) {
 .image-container {
 width: 100% !important;
 float: none !important;
 margin: 0 0 1rem 0 !important;
 }
 }

Image source: The Mo...

Compared to Estimates, Transcat (TRNS) Q4 Earnings: A Look at Key Metrics

While the top- and bottom-line numbers for Transcat (TRNS) give a sense of how the business performed in the quarter ended March 2026, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.

Full Transcript: Transcat Q4 2026 Earnings Call

Transcat, Inc. (TRNS) Q4 Earnings Surpass Estimates

Transcat (TRNS) delivered earnings and revenue surprises of +9.80% and -1.65%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?

Transcat Reports Strong Fiscal Fourth Quarter 2026 Financial Results with Continued High Single-Digit Service Organic Revenue* Growth

Transcat, Inc. (Nasdaq: TRNS) (Transcat or the Company), a leader in test measurement, control and calibration, has reported financial and operational results for its fiscal fourth quarter and year ended March 28, 2026 (fiscal 2026). Management Commentary Transcat achieved robust results across...

Transcat (TRNS) Q2 2026 Earnings Transcript

Transcat TRNS Q3 2026 Earnings Call Transcript

Gear Up for Transcat (TRNS) Q4 Earnings: Wall Street Estimates for Key Metrics

Evaluate the expected performance of Transcat (TRNS) for the quarter ended March 2026, looking beyond the conventional Wall Street top-and-bottom-line estimates and examining some of its key metrics for better insight.

Transcat to Host Fourth Quarter Fiscal Year 2026 Conference Call and Webcast on Tuesday, May 26, 2026 at 4:30 p.m. Eastern Time

Transcat, Inc. (Nasdaq: TRNS) (Transcat or the Company), a leading provider of test measurement, control and calibration services, announced that it will release its results for the fourth quarter...

Transcat, Inc. engages in the provision of calibration and laboratory instrument services. It operates through the following business segments: Service and Distribution. The Service segment offers calibration, repair, inspection, analytical qualifications, preventive maintenance, consulting, and other related services. The Distribution segment distributes professional grade tests, measurement, and control instrumentation. The company was founded in 1964 and is headquartered in Rochester, NY.

Fiscal Period	Estimated	Reported	Surprise	Result
Q1 '26	$0.38	--	--	N/A
Q4 '25	$0.56	$0.56	0.45%	BEAT
Q3 '25	$0.31	$0.26	-17.46%	MISSED
Q2 '25	$0.48	$0.44	-9.09%	MISSED
Q1 '25	$0.40	$0.59	48.99%	BEAT

TRNSTranscat Inc

Fundamentals

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest Earnings Results: Q4 '25

Historical Earnings

Latest TRNS News